Skip to main content

Advertisement

Table 2 aMutual predicatbility score of breast cancer drug candiates predicted by MFM

From: A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer

FDA Drug aMP score P-value FDR
Clotrimazole 0.7 5.00E-06 4.88E-05
Triprolidine 0.69 2.00E-05 1.64E-04
Thioridazine 0.69 2.00E-05 1.64E-04
Mefloquine 0.69 3.00E-05 2.28E-04
Fluphenazine 0.66 1.11E-02 2.13E-02